Solid Biosciences

$7.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.25 (-3.06%) As of 3:53 PM UTC today

Why Robinhood?

You can buy or sell SLDB and other stocks, options, and ETFs commission-free!

About SLDB

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA. The listed name for SLDB is Solid Biosciences Inc. Common Stock.

CEO
Ilan Ganot
Employees
121
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
700.18M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.49M
High Today
$8.50
Low Today
$7.61
Open Price
$8.11
Volume
329.28K
52 Week High
$11.58
52 Week Low
$1.93

SLDB Earnings

-$0.85
-$0.57
-$0.28
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 15

You May Also Like

BFIN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure